Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2019 Mar;49(4):617-627.
doi: 10.1017/S0033291718001307. Epub 2018 Jun 4.

Biomarker-based subtyping of depression and anxiety disorders using Latent Class Analysis. A NESDA study

Affiliations
Multicenter Study

Biomarker-based subtyping of depression and anxiety disorders using Latent Class Analysis. A NESDA study

Lian Beijers et al. Psychol Med. 2019 Mar.

Abstract

Background: Etiological research of depression and anxiety disorders has been hampered by diagnostic heterogeneity. In order to address this, researchers have tried to identify more homogeneous patient subgroups. This work has predominantly focused on explaining interpersonal heterogeneity based on clinical features (i.e. symptom profiles). However, to explain interpersonal variations in underlying pathophysiological mechanisms, it might be more effective to take biological heterogeneity as the point of departure when trying to identify subgroups. Therefore, this study aimed to identify data-driven subgroups of patients based on biomarker profiles.

Methods: Data of patients with a current depressive and/or anxiety disorder came from the Netherlands Study of Depression and Anxiety, a large, multi-site naturalistic cohort study (n = 1460). Thirty-six biomarkers (e.g. leptin, brain-derived neurotrophic factor, tryptophan) were measured, as well as sociodemographic and clinical characteristics. Latent class analysis of the discretized (lower 10%, middle, upper 10%) biomarkers were used to identify different patient clusters.

Results: The analyses resulted in three classes, which were primarily characterized by different levels of metabolic health: 'lean' (21.6%), 'average' (62.2%) and 'overweight' (16.2%). Inspection of the classes' clinical features showed the highest levels of psychopathology, severity and medication use in the overweight class.

Conclusions: The identified classes were strongly tied to general (metabolic) health, and did not reflect any natural cutoffs along the lines of the traditional diagnostic classifications. Our analyses suggested that especially poor metabolic health could be seen as a distal marker for depression and anxiety, suggesting a relationship between the 'overweight' subtype and internalizing psychopathology.

Keywords: Anxiety; biomarkers; depression; latent class analysis; subtyping.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Probabilities to score in the lowest (left) or highest (right) 10-th percentile of each variable for the different latent classes in the sample including subjects with current psychopathology. A = Lean (21.6%), B = Average (62.2%), C = Overweight (16.2%). Color groups consist of biomarkers with similar themes, as indicated in online Supplementary Table S1. Abbreviations: Blood pressure, combination of systolic and diastolic pressure; T4, free thyroxine; TSH, thyroid stimulating hormone; PTH, parathyroid hormone; CAR, cortisol awakening response; AUCg, area under the curve with respect to the ground, AUCi, area under the curve with respect to increase; DHEA(-S), dehydroepiandrosterone(-sulphate); HRV, heart rate variability; HRV reactivity, combination of HRV reactivity in both stress situations; BDNF, brain-derived neurotrophic factor, IGF-1 insulin-like growth factor 1; E2, estradiol; SHBG, sex hormone binding globulin; IL-6, interleukin 6; TNFa, tumor necrosis factor alpha; hsCRP, C-reactive protein; GAMMA, gamma-glutamyltransferase; ASAT/ALAT, combination of aspartate aminotransferase and, alanine aminotransferase; hematology, combination of hemoglobin, hematocrit, and erythrocyte values.

References

    1. Abosi O, Lopes S, Schmitz S and Fiedorowicz JG (2018) Cardiometabolic effects of psychotropic medications. Hormone Molecular Biology and Clinical Investigation [Epub ahead of print]. - PMC - PubMed
    1. Bartova L, Berger A and Pezawas L (2010) Is there a personalized medicine for mood disorders? European Archives of Psychiatry and Clinical Neuroscience 260, 121–126. - PubMed
    1. Baumeister H and Parker G (2012) Meta-review of depressive subtyping models. Journal of Affective Disorders 139, 126–140. - PubMed
    1. Beck AT, Epstein N, Brown G and Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology 56, 893. - PubMed
    1. Benjamini Y and Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society 57, 289–300.

Publication types